• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Pharmacokinetic studies on clopenthixol decanoate; a comparison with clopenthixol in dogs and rats.

作者信息

Aaes-Jorgensen T, Overo K F, Bogeso K P, Jorgensen A

出版信息

Acta Pharmacol Toxicol (Copenh). 1977 Aug;41(2):103-20.

PMID:579050
Abstract

The release from the depot, hydrolysis and distribution in the organsim as well as the metabolism and elimination of intramuscularly injected clopenthixol decanoate in Viscoleo have been studied in dogs and rats with radioactive as well as non-labelled drug after single as well as repeated administration. The studies clearly demonstrate the depot effect of clopenthixol decanoate given intramuscularly in oil compared to orally administered clopenthixol. The amounts of drug remaining at the site of injection in dogs suggest monoexponential release of drug from the depot and a half-life of 4-5 days. Rapid hydrolysis to clopenthixol in the organism was indicated by in vitro experiments and in vivo findings. Clopenthixol was found to be the main compound in the organism after single as well as repeated doses. The clopenthixol formed by hydrolysis appeared to be metabolized in the same way as clopenthixol given orally i.e. by dealkylation of the side chain and by S-oxide and N-oxide formation. The elimination pattern with predominant fecal excretion also appeared to be the same after clopenthixol and its esterified derivative apart from the reflection in the latter case of the slow release from depot. A rapid exchange in the organism between tritium from the drugs and hydrogen from the body water was demonstrated. This has to be considered in studies with tritium labelled drugs, where estimation of total radioactivity gives the sum of tritium in drug, metabolites and water.

摘要

相似文献

1
Pharmacokinetic studies on clopenthixol decanoate; a comparison with clopenthixol in dogs and rats.
Acta Pharmacol Toxicol (Copenh). 1977 Aug;41(2):103-20.
2
Pharmacology of cis(Z)-clopenthixol decanoate, a depot neuroleptic.
Acta Pharmacol Toxicol (Copenh). 1977 Apr;40(4):482-90.
3
Serum concentrations of the isomers of clopenthixol and a metabolite in patients given cis(Z)-clopenthixol decanoate in viscoleo.
Psychopharmacology (Berl). 1983;81(1):68-72. doi: 10.1007/BF00439276.
4
Clopenthixol and flupenthixol depot preparations in outpatient schizophrenics. III. Serum levels.
Acta Psychiatr Scand Suppl. 1980;279:41-54. doi: 10.1111/j.1600-0447.1980.tb07082.x.
5
A specific method for assay of drug levels in serum of patients treated with clopenthixol decanoate injections.
Acta Psychiatr Scand Suppl. 1980;279:92-103. doi: 10.1111/j.1600-0447.1980.tb07086.x.
6
[cis(Z)-Clopenthixol decanoate--a new depot neuroleptic].[顺式(Z)-癸酸氯哌噻吨——一种新型长效抗精神病药]
Int Pharmacopsychiatry. 1982;17(3):170-84.
7
Clinical pharmacokinetics of the depot antipsychotics.长效抗精神病药物的临床药代动力学
Clin Pharmacokinet. 1985 Jul-Aug;10(4):315-33. doi: 10.2165/00003088-198510040-00003.
8
[A new injectable delayed-action neuroleptic with sedative and antipsychotic action: cis-(Z)-clopenthixol decanoate. Clinical trials].
Encephale. 1984;10(2):83-91.
9
Fluctuation of serum zuclopenthixol concentrations in patients treated with zuclopenthixol decanoate in viscoleo.
Ther Drug Monit. 1994 Apr;16(2):155-9. doi: 10.1097/00007691-199404000-00008.
10
Absorption, distribution, metabolism, and excretion of N,N-diethyl-M-toluamide in the rat.N,N-二乙基间甲苯酰胺在大鼠体内的吸收、分布、代谢及排泄
Drug Metab Dispos. 1996 Feb;24(2):156-63.

引用本文的文献

1
Serum concentrations of the isomers of clopenthixol and a metabolite in patients given cis(Z)-clopenthixol decanoate in viscoleo.
Psychopharmacology (Berl). 1983;81(1):68-72. doi: 10.1007/BF00439276.
2
Comparative study of the pharmacokinetics of zuclopenthixol decanoate and fluphenazine decanoate.癸酸珠氯噻醇与癸酸氟奋乃静的药代动力学对比研究。
Psychopharmacology (Berl). 1988;94(3):293-7. doi: 10.1007/BF00174677.
3
Serum concentrations and clinical effect of zuclopenthixol in acutely disturbed, psychotic patients treated with zuclopenthixol acetate in Viscoleo.
Psychopharmacology (Berl). 1986;90(3):412-6. doi: 10.1007/BF00179201.
4
Clinical pharmacokinetics of the depot antipsychotics.长效抗精神病药物的临床药代动力学
Clin Pharmacokinet. 1985 Jul-Aug;10(4):315-33. doi: 10.2165/00003088-198510040-00003.
5
Pharmacokinetics of long-acting injectable neuroleptic drugs: clinical implications.长效注射用抗精神病药物的药代动力学:临床意义。
Psychopharmacology (Berl). 1989;98(4):433-9. doi: 10.1007/BF00441937.